日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下，新型雄激素受体抑制剂氘代沙鲁胺的疗效：来自随机 III 期 HC-1119-04 试验的结果

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02618-3
Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Implantable soft bladder-machine interface for neurogenic bladder dysfunction

用于治疗神经源性膀胱功能障碍的可植入式软性膀胱-机器接口

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-70680-0
Li, Hanfei; Wang, Shuai; Yu, Qianhengyuan; Zhao, Hang; Tang, Zhuochao; Lv, Linchen; Han, Fei; Yang, Ruofan; Zhao, Yang; Fu, Zhuojia; Shi, Benkang; Li, Guanglin; Wang, Changxian; Zhang, Jie; Song, Kaikai; Li, Yan; Liu, Zhiyuan
发表日期：2026
文献求助 收藏

Intravesical instillation of pirfenidone/polydopamine nanoparticles for managing neurogenic bladder post-spinal cord injury by alleviating bladder inflammation and fibrosis.

通过膀胱内灌注吡非尼酮/聚多巴胺纳米颗粒治疗脊髓损伤后神经源性膀胱，减轻膀胱炎症和纤维化。

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-026-04025-w
Zhang Jizheng, Li Hui, Zhang Lekai, Lv Linchen, Zang Maolin, Wang Xinyv, Wang Shuai, Chen Lipeng, Yang Zizhuo, Yang Liang, Zhao Jianyou, Gao Xindong, Guo Dongyue, Shi Benkang, Zhang Zhiyue, Li Yan
炎症/感染
脊髓损伤
炎症
神经科学
发表日期：2026
文献求助 收藏

Patient-derived kidney organoids recapitulate ADPKD and facilitate the identification of Rho pathway inhibitors as candidate therapeutics

患者来源的肾脏类器官能够重现 ADPKD 的病理过程，并有助于鉴定 Rho 通路抑制剂作为候选治疗药物。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102720
Guo, Liqiang; Fan, Yujia; Sun, Huixian; Du, Haoran; Xiong, Hui; Li, Yilin; Zhang, Xinyan; Guan, Yong; Ren, Lingtong; Wang, Xuan; Chen, Kai; An, Yachun; Zhang, Xiaohui; Mao, Yunuo; Gong, Yongfeng; Kong, Feng; Qiu, Jichuan; Chen, Rui; Shi, Benkang; Yi, Fan; Hu, Huili; Zhao, Shengtian
信号转导
3D/类器官
发表日期：2026
文献求助 收藏

PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6.

PRDM1 通过抑制 OTUD6A 介导的 CDC6 去泛素化来限制膀胱癌的进展并增强化疗敏感性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08498-3
Cui Jianfeng, Chen Shouzhen, Liu Xiaochen, Jiang Xuewen, Cheng Guangzhou, Liu Zhifeng, Zhao Hui, Zhu Yaofeng, Shi Benkang, Zou Yongxin
膀胱癌
肿瘤
CDC6
PRDM1
泛素化
发表日期：2026
文献求助 收藏

Artificial intelligence diagnostics for bladder tumor identification and grade prediction depend on narrow band imaging cystoscopy

人工智能诊断膀胱肿瘤的识别和分级预测依赖于窄带成像膀胱镜检查。

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.114309
Wang, Yinchao; Liang, Hao; Zhang, Yaozhong; Qi, Wenqiang; Wu, Guangping; Zhang, Xiaoyi; Li, Chuanpeng; Chen, Shouzhen; Chen, Jun; Shi, Benkang
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Duodenal perforation after retroperitoneal laparoscopic radical nephrectomy for ruptured malignant renal PEComa with spontaneous retroperitoneal hemorrhage: a case report

一例因恶性肾脏PEComa破裂伴自发性腹膜后出血行腹膜后腹腔镜根治性肾切除术后发生十二指肠穿孔的病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1792626
Guo, Juncheng; Cai, Xun; Shen, Shiju; Jiang, Xianzhou; Zhang, Zhaocun; Shi, Benkang
发表日期：2026
文献求助 收藏

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.

SMYD3 通过 SREBP1 介导的 CD47 反式激活促进透明细胞肾细胞癌的免疫逃逸。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202404200
Liu Zhengfang, Zhao Xiumei, Zang Maolin, Yuan Huiyang, Qin Xin, Li Xiaofeng, Zhao Shuo, Tan Ruirong, Yan Keqiang, Liu Li, Fan Yidong, Zhang Ning, Shi Benkang, Han Bo, Chen Shouzhen
细胞生物学
T细胞
CD4
EBP
CD47
EBP1
SMYD3
发表日期：2025
文献求助 收藏

CAMK1D activates AMPK/PINK1/Parkin-dependent mitophagy to promote enzalutamide resistance in prostate cancer

CAMK1D激活AMPK/PINK1/Parkin依赖性线粒体自噬，从而促进前列腺癌对恩扎卢胺的耐药性

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-08342-0
Sun, Feifei; Qu, Ying; Mei, Shuyu; Zhang, Lin; Shao, Xianhao; Wang, Xinpei; Liu, Shijia; Wang, Meng; Liu, Wenyao; Yang, Muyi; Hu, Jing; Shi, Benkang; Gao, Lin; Han, Bo
PINK1
肿瘤
肿瘤免疫
NK1
线粒体
Parkin
AMPK
前列腺癌
自噬
发表日期：2025
文献求助 收藏

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer

一项随机、开放标签、多中心、活性对照的II期研究，比较改良制剂醋酸阿比特龙片（II）与原研醋酸阿比特龙在转移性去势抵抗性前列腺癌患者中的疗效。

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04053-7
Lu, Xiaolin; Dai, Tao; Chen, Xue; Wu, Bin; Chen, Hui; Wu, Jitao; Yu, Dexin; Ge, Huixin; Li, Jian; Huang, Houbao; Fan, Tiwu; Cheng, Linzhong; Zhang, Xiaoping; Zhang, Xuepei; Yao, Xin; Wei, Junli; Xu, Zhenqiang; Yang, Wenzeng; He, Chaohong; Luo, Jiexin; Guan, Ling; Fu, Bin; Wang, Qilin; Chen, Xiaofeng; Zhang, Yongdong; Shi, Benkang; Zheng, Bin; Wang, Yong; Luo, Hong; Chen, Guoqiang; Wang, Huan; Wang, Quanren; Ye, Dingwei
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏